Health TrialsbyHealthPanel

Epcoritamab

1

Review clinical trials related to Epcoritamab. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphoma

To compare the time to next treatment between patients with previously untreated, low tumor burden FL who receive the study drug epcoritamab versus those who do not receive epcoritamab and are monitored only.

Participants needed: 40
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Sep 23, 2026Locations: 1
Eligibility criteria

Histologically diagnosed follicular lymphoma grade 1-3a [+27]

Known active central nervous system lymphoma or leptomeningeal disease [+20]

Read more